Viewing nowCombinationVytorin Tablets 10/20
Simvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.

MFDS item code 200511263 · Approved 2005.01.31 · Insurance code 073100070
Improvement of hypercholesterolemia (primary or homozygous familial) and mixed hyperlipidemia
This medication helps to reduce total cholesterol, LDL cholesterol, ApoB protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia while increasing HDL cholesterol. It can be used as an adjunct to other therapies or as monotherapy in patients with homozygous familial hypercholesterolemia. This medication should be used in conjunction with an appropriate dietary regimen that restricts saturated fats and cholesterol, and is prescribed as an adjunct when dietary changes alone are insufficient. Before starting treatment, it is important to identify and treat any secondary causes such as diabetes or hypothyroidism. During treatment, total cholesterol, LDL, HDL, and triglyceride levels should be regularly monitored and managed. This medication is used to improve blood lipid levels and reduce the risk of atherosclerotic disease.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, the recommended treatment goal, and the patient's response. This medicine is administered once daily in the evening, regardless of meals. Patients with primary hypercholesterolemia The dose range of this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of 4 weeks or longer and then adjust the dose. Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have been taking 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary for patients with mild hepatic impairment; however, administration of this medicine is not recommended for patients with moderate or severe hepatic impairment (see the section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is necessary for patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Exercise caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary when administering this medicine to elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this medicine.
This medication is primarily used to lower cholesterol levels in the blood. During treatment, muscle-related symptoms may occur, which can manifest as muscle pain or weakness, and in severe cases, can lead to rhabdomyolysis due to muscle tissue destruction. The risk of these symptoms increases with high doses or concurrent use with certain medications, so caution is advised. This medication should not be used in patients with severe liver disease or persistent unexplained elevation of liver enzymes, in women who are pregnant or breastfeeding, or in cases of concurrent administration with certain medications. Additionally, administration is contraindicated in patients with certain genetic disorders due to the ingredients in this medication. Patients with muscle weakness or muscle weakness around the eyes should use this medication with caution, and discontinue use immediately if symptoms worsen. While taking this medication, if muscle pain, muscle weakness, or unexplained muscle-related symptoms occur, notify a doctor immediately, and muscle enzyme testing may be required. Liver function abnormalities may occur, making regular liver function tests important before and during treatment. This medication can interact with multiple drugs, and especially when taken with medications that inhibit liver enzymes responsible for drug metabolism, the risk of muscle-related side effects may increase, so it is crucial to inform the doctor about all medications currently being taken. During pregnancy, this medication may harm the fetus, so it should not be taken if planning a pregnancy or during pregnancy; fertile women should only take it when the possibility of pregnancy is low. Women who are breastfeeding should also refrain from using this medication. The safety for children and adolescents has not been sufficiently established, so it should be used carefully under the guidance of a specialist. The elderly may respond more sensitively to this medication, requiring caution. In case of overdose, there is no specific antidote, so it is essential to receive appropriate treatment based on symptoms. When taking this medication, regular check-ups and strict adherence to the doctor's instructions are advisable for safety.
Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, arthralgia, myalgia, elevated creatine phosphokinase, elevated liver aminotransferases, hepatitis, abdominal pain, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, drug reaction with accompanying systemic symptoms, erythema multiforme, myasthenia, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, taste disturbances, ocular motility disorders, facial incomplete paralysis, tremor, peripheral neuropathy, peripheral nerve palsy, mental disorders, anxiety, sleep disturbances, memory decline, forgetfulness, amnesia, memory impairment, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, photosensitivity, fever, chills, flushing, malaise, dyspnea, cholecystic jaundice, liver fat changes, cirrhosis, fulminant liver necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferases, elevated ALP, increased gamma-GT, elevated bilirubin, thyroid dysfunction, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial edema, syncope, insomnia, gastritis, atrophic gastritis, mucus stool, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture and should be stored in a tight container. To maintain its effectiveness, it is best to store it at room temperature between 1°C and 30°C.
White to off-white, capsule-shaped tablet with a convex shape, marked with 312 on one side.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.